Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Wound Care
- Drugs
- Beauty Aid
- Consumer Goods
- Retail & Leisure
- Medical
- Textiles
- Supply
- Health & Fitness
- Personal Care Products
- Therapeutic
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 117988
License Grant
The Licensor, an entity controlled by one of the Licensee's directors, has granted the Licensee an exclusive right to all of its technology in the Licensees principal fields of interest, and rights of first refusal in certain other fields. The Licensee has developed two product lines in the past several years, a line of synthetic dressings for the treatment of chronic wounds, and a line of moisturizing creams and gels for the consumer skin care markets.
License Property
The Licensor is involved in producing polymer compositions and thin film hydrophilic coatings.
Field of Use
The Licensee is involved in the development and commercialization of medical and skin care
products based on its proprietary synthetic HYPAN-Registered Trademark-hydrogels and memory polymers.
IPSCIO Record ID: 5848
License Grant
The Company, on behalf of a wholly-owned subsidiary to be formed, entered into a manufacturing agreement with an entity affiliated with a director of the Company. The agreement grants the Company the exclusive rights to manufacture patented hydrophilic urethane foam products, polyurethane gels and moisture managed foam footwear inserts and to distribute, along with the Licensor, these products in North America. The manufacturing agreement also provides for a supply agreement between the two companies.
License Property
Licensor is the owner of substantial technology, issued and pending U.S. and foreign patents, Know-How (as such term is defined below) and proprietary information (collectively, the 'Technology') for the production and manufacture
of hydrophilic urethane foam products and polyurethane gels, components and materials (the 'Products').
Trademarks Silverwear(TM) and Dryz Gelz(TM)
Patents
1. US Pat No. 5,976,616 – Polyurethane Foam Materials With Skin Conditioning Additives
2. US Pat No. 6,566,576 B1 – Hydrocolloid Foam Medical Dressings and Method Of Making The Same
3. US Patent No. 6,706,775 – Polyurethane Foam Products with Controlled release of Agents and Additives
4. US Patent Application – Elastic bandage incorporating a Hydrophilic foam dressing
5. US Patent Application – Elastomeric Matrix with Fragrance Comprising a Synthetic Vapor Permeable Film To Control Release
Dryz Patents
6. US PAT NO. 5,763,335
7. US PAT NO. 6,025,287
Field of Use
Products manufactured under this agreement are being sold for use in cosmetic, medical, and household markets including the foot-care market under the brand name DRYZ, a registered trademark. In December 2005, the subsidiary was formed as a wholly-owned subsidiary of the Company to control this activity.
IPSCIO Record ID: 275061
License Grant
Licensee acquired an exclusive world-wide license to market, sell and further develop antimicrobial products utilizing certain Licensor patents and pending patent applications. A director and indirect principal shareholder of Licensee is also a director of Licensor, and indirectly a significant shareholder of Licensor, and through the potential exercise of warrants a majority shareholder.
License Property
Currently, the products covered by the License Agreement are BIAKOSâ„¢ Antimicrobial Wound Gel, and FDA cleared BIAKOSâ„¢ Antimicrobial Skin and Wound Cleanser.
Field of Use
The field of use is for the prevention and treatment of microbes on the human body. The agreement pertains to the wound care industry.
IPSCIO Record ID: 614
License Grant
The Licensors grants the Licensee a non-revocable, exclusive, sub-licensable, transferable right in and to the Licensed IP to make, have made, use, sell, export, reproduce, market and distribute Products for External Wound Care in the field of use.
License Property
External Wound Care means the treatment of external, tunneled or undermined wounds (including, without limitation, pressure ulcers (Stages I – IV), venous stasis ulcers, diabetic ulcers, ulcers resulting from arterial insufficiency, surgical wounds, traumatic wounds, first and second degree burns, superficial wounds, cuts scrapes, skin tears, skin flaps and skin grafts.
Patent means – United States Patent No. 6,136,341.
The patented technologies and processes related to CellerateRxTM, an advanced collagen based wound care product formulation. These new licenses are limited to the human health care market for external wound care, and include any new product developments based on the licensed patent and processes.
Field of Use
The Field of Use means the worldwide human health care market, (excluding the veterinary, nutritional and injectable markets as well as all other uses) and subject to certain exceptions.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
